Aldeyra Therapeutics Inc (ALDX)
EBITDA Margin
-465.86%
TTM · Period ending:
ALDX EBITDA Margin
Latest reported-465.86%period ending
Latest reported-465.86%period ending
ALDX TTM EBITDA Margin (4512.91% → -465.86%)
TTM ebitda margin
High-resolution chart · PNG
ALDX ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -465.857% | |
| -0.0001% | |
| -0.0001% | |
| -0.0001% | |
| -0.0001% | |
| -98.8293% | |
| -97.7892% | |
| -92.7898% | |
| -115.1508% | |
| 6,890.2075% | |
| 6,358.7521% | |
| 5,579.6736% | |
| 4,512.9068% |